-
2024-514991-41-01
4
Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
-
2022-501697-19-00
5
Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Lymphocytic Leuke
-
2023-510033-28-00
4
allergic rhinoconjunctivitis caused due to exposure to pollen grasses
-
2024-510582-42-00
4
Acute graft versus host disease (aGvHD)
-
2024-512754-16-00
5
Prostate cancer
-
2025-520581-22-00
4
Allergic rhinoconjunctivitis caused due to exposure to pollen grasses
-
2025-523139-21-00
9
Patients who have developed acute GVHD refractory to corticosteroids a
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-510163-35-00
5
Acute Alcoholic hepatitis
-
2024-513676-18-00
5
Transthyretin Amyloidosis
-
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
-
2024-518026-32-00
5
Invasive Breast Cancer
-
2024-518231-11-00
4
Immune thrombocytopenia (ITP)
Warm autoimmune hemolytic anemia (wAIHA
-
2024-518420-80-00
5
Primary infection prophylaxis for secondary immunodeficiency (SID) in
-
2024-518786-10-01
4
Moderate to Severe Chronic Spontaneous Urticaria
-
2024-519709-37-00
5
Paroxysmal nocturnal hemoglobinuria (PNH)
-
2024-519772-10-00
4
Dry eye disease in patients with Graft versus Host disease patients
-
2024-519994-20-00
5
Agitation Associated with Alzheimer’s Disease
-
2024-520020-28-00
7
Cytomegalovirus infection post allogeneic allogeneic HLA-identical fam
-
2024-520218-23-00
10
Pulmonary Arterial Hypertension
-
2025-520954-12-00
6
Atrial Fibrillation
Device thrombosis post-Left Atrial Appendage Closu
-
2025-521126-15-00
4
Chronic Myeloid Leukemia
-
2025-521209-42-00
6
advanced colorectal cancer with wild-type RAS and right primary tumour
-
2025-521709-42-00
5
Allergic rhinoconjunctivitis with or without asthma due to clinically